Literature DB >> 17689134

Promoter hypermethylation of CCNA1, RARRES1, and HRASLS3 in nasopharyngeal carcinoma.

Pattamawadee Yanatatsaneejit1, Thep Chalermchai, Veerachai Kerekhanjanarong, Kanjana Shotelersuk, Pakpoom Supiyaphun, Apiwat Mutirangura, Virote Sriuranpong.   

Abstract

In search for putative tumor suppressor genes critical of nasopharyngeal carcinoma (NPC), we analyzed the available information from the expression profiling in conjunction with the comprehensive alleotyping published data relevant to this malignancy. Integration of this information suggested eight potential candidate tumor suppressor genes, CCNA1, HRASLS3, RARRES1, CLMN, EML1, TSC22, LOH11CR2A and MCC. However, to confirm the above observations, we chose to investigate if promoter hypermethylation of these candidate genes would be one of the mechanisms responsible for the de-regulation of gene expression in NPC in addition to the loss of genetic materials. In this study, we detected consistent hypermethylation of the 5' element of CCNA1, RARRES1, and HRASLS in NPC tissues with prevalence of 48%, 51%, and 17%, respectively. Moreover, we found a similar profile of promoter hypermethylation in primary cultured NPC cells but none in normal nasopharyngeal epithelium or leukocytes, which further substantiate our hypothesis. Our data indicate that CCNA1, RARRES1, and HRASLS3 may be the putative tumor suppressor genes in NPC.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17689134     DOI: 10.1016/j.oraloncology.2007.05.008

Source DB:  PubMed          Journal:  Oral Oncol        ISSN: 1368-8375            Impact factor:   5.337


  21 in total

1.  Identification of RARRES1 as a core regulator in liver fibrosis.

Authors:  Andreas Teufel; Diana Becker; Susanne N Weber; Steven Dooley; Katja Breitkopf-Heinlein; Thorsten Maass; Katrin Hochrath; Markus Krupp; Jens U Marquardt; Martin Kolb; Bernhard Korn; Christof Niehrs; Tim Zimmermann; Patricio Godoy; Peter R Galle; Frank Lammert
Journal:  J Mol Med (Berl)       Date:  2012-06-06       Impact factor: 4.599

Review 2.  Epstein-Barr virus: a master epigenetic manipulator.

Authors:  Rona S Scott
Journal:  Curr Opin Virol       Date:  2017-08-04       Impact factor: 7.090

3.  The DNA binding factor Hmg20b is a repressor of erythroid differentiation.

Authors:  Fatemehsadat Esteghamat; Thamar Bryn van Dijk; Harald Braun; Sylvia Dekker; Reinier van der Linden; Jun Hou; Pavlos Fanis; Jeroen Demmers; Wilfred van IJcken; Zeliha Ozgür; Rastislav Horos; Farzin Pourfarzad; Marieke von Lindern; Sjaak Philipsen
Journal:  Haematologica       Date:  2011-05-23       Impact factor: 9.941

4.  Epigenetic field alterations in non-tumor prostate tissues detect prostate cancer in urine.

Authors:  Tariq A Khemees; Bing Yang; Adam Schultz; Glenn O Allen; Joseph Gawdzik; Aman Nihal; Kyle A Richards; E Jason Abel; David F Jarrard
Journal:  Am J Clin Exp Urol       Date:  2021-12-15

5.  Tumor Suppressor RARRES1 Regulates DLG2, PP2A, VCP, EB1, and Ankrd26.

Authors:  Ziad J Sahab; Michael D Hall; Lihua Zhang; Amrita K Cheema; Stephen W Byers
Journal:  J Cancer       Date:  2010-06-02       Impact factor: 4.207

6.  Role of DNA methylation in head and neck cancer.

Authors:  Semra Demokan; Nejat Dalay
Journal:  Clin Epigenetics       Date:  2011-07-09       Impact factor: 6.551

7.  Correlation of CCNA1 promoter methylation with malignant tumors: a meta-analysis introduction.

Authors:  Bin Yang; Shuai Miao; Le-Ning Zhang; Hong-Bin Sun; Zhe-Nan Xu; Chun-Shan Han
Journal:  Biomed Res Int       Date:  2015-01-15       Impact factor: 3.411

8.  Retinoic acid represses invasion and stem cell phenotype by induction of the metastasis suppressors RARRES1 and LXN.

Authors:  E E Oldridge; H F Walker; M J Stower; M S Simms; V M Mann; A T Collins; D Pellacani; N J Maitland
Journal:  Oncogenesis       Date:  2013-04-15       Impact factor: 7.485

Review 9.  The HRASLS (PLA/AT) subfamily of enzymes.

Authors:  Emily B Mardian; Ryan M Bradley; Robin E Duncan
Journal:  J Biomed Sci       Date:  2015-10-26       Impact factor: 8.410

10.  Human papillomavirus type 16 E7 oncoprotein mediates CCNA1 promoter methylation.

Authors:  Kanwalat Chalertpet; Watcharapong Pakdeechaidan; Vyomesh Patel; Apiwat Mutirangura; Pattamawadee Yanatatsaneejit
Journal:  Cancer Sci       Date:  2015-09-25       Impact factor: 6.716

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.